首页/数据集/MOESM1 of Quantitative proteomic characterization of lung tissue in idiopathic pulmonary fibrosis

MOESM1 of Quantitative proteomic characterization of lung tissue in idiopathic pulmonary fibrosis

NIAID Data Ecosystem2026-03-10 收录

数据链接：

https://figshare.com/articles/dataset/MOESM1_of_Quantitative_proteomic_characterization_of_lung_tissue_in_idiopathic_pulmonary_fibrosis/7686554 数据链接链接失效反馈

官方服务：

资源简介：

Additional file 1. The distribution of peptide length.

应用场景：

创建时间：

2019-02-07

相关数据集

UNAGI_Based特发性肺纤维化蛋白质组学研究数据

特发性肺纤维化基因组学

药物发现

本数据集为UNAGI论文配套的特发性肺纤维化（IPF）蛋白质组学数据，包含三十例IPF供体和十例对照供体组织块的蛋白质表达信息，经log2转换和z-score标准化处理，还通过ANOVA和Student’s T-test筛选差异表达蛋白，共一个文件。 UNAGI论文“A deep generative model for deciphering cellular dynamics and in s

海数据60

Genome Sequencing of Idiopathic Pulmonary Fibrosis in Conjunction with a Medical School Human Anatomy Course

特发性肺纤维化基因组学

医学教育整合

Even in cases where there is no obvious family history of disease, genome sequencing may contribute to clinical diagnosis and management. Clinical application of the genome has not yet become routine,

Figshare2016-01-15 更新20

Genomic differences distinguish the myofibroblast phenotype of distal lung from airway fibroblasts

特发性肺纤维化基因组学

呼吸系统重塑机制

ABSTRACT Primary human distal lung/parenchymal fibroblasts (DLF) exhibit a different phenotype from airway fibroblasts (AF), including the expression of high levels of a-smooth muscle actin (a-SMA).

NIAID Data Ecosystem20

DataSheet1_Changes in serum metabolomics in idiopathic pulmonary fibrosis and effect of approved antifibrotic medication.docx

特发性肺纤维化基因组学

抗纤维化药物

Idiopathic pulmonary fibrosis (IPF) is a progressive disease with significant mortality and morbidity. Approval of antifibrotic therapy has ameliorated disease progression, but therapy response is het

NIAID Data Ecosystem40

Microbiome in Lung Explant: an IPF Study

特发性肺纤维化基因组学

肺组织微生物组特征分析

To characterize the regional IPF lung tissue microbiome in the Microbiome In Lung Explants Study

NIAID Data Ecosystem20